Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …

Abstract Purpose of Review To review the recent available evidence on epidemiology,
pathogenesis, clinical phenotypes, and management of antiphospholipid syndrome (APS) …

Antiphospholipid antibody syndrome (APS) is an autoimmune acquired thrombophilia
characterized by recurrent thrombosis and pregnancy morbidity in the presence of …

Antiphospholipid syndrome (APS) is defined by clinical manifestations that include
thrombosis and/or fetal loss or pregnancy morbidity in patients with antiphospholipid …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by the
persistent positivity of antiphospholipid antibodies (aPLA) together with thrombosis or …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid syndrome (APS) is a systemic disorder clinically characterized by
widespread thrombosis and obstetric complications associated with the persistent presence …

Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL) …